These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25423626)

  • 1. Surgical management of symptomatic vitreous floaters.
    Danzig C; Hariprasad SM
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):1-3. PubMed ID: 25423626
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review.
    Ivanova T; Jalil A; Antoniou Y; Bishop PN; Vallejo-Garcia JL; Patton N
    Eye (Lond); 2016 May; 30(5):645-55. PubMed ID: 26939559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitrectomy for vitreous floaters: analysis of the benefits and risks.
    Sommerville DN
    Curr Opin Ophthalmol; 2015 May; 26(3):173-6. PubMed ID: 25784107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters.
    Vandorselaer T; Van De Velde F; Tassignon MJ
    Bull Soc Belge Ophtalmol; 2001; (280):15-9. PubMed ID: 11486460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery for floaters.
    Mura M; Engelbrecht LA; de Smet MD; Papadaki TG; van den Berg TJ; Tan HS
    Ophthalmology; 2011 Sep; 118(9):1894-1894.e1. PubMed ID: 21889665
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitreous management during complicated cataract surgery.
    Prasad S
    Ann Ophthalmol (Skokie); 2008; 40(3-4):123-9. PubMed ID: 19230347
    [No Abstract]   [Full Text] [Related]  

  • 7. To Treat or Not to Treat: Management Options for Symptomatic Vitreous Floaters.
    Broadhead GK; Hong T; Chang AA
    Asia Pac J Ophthalmol (Phila); 2020; 9(2):96-103. PubMed ID: 32097127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Symptomatic Floaters: Current Attitudes, Beliefs, and Practices Among Vitreoretinal Surgeons.
    Cohen MN; Rahimy E; Ho AC; Garg SJ
    Ophthalmic Surg Lasers Imaging Retina; 2015 Sep; 46(8):859-65. PubMed ID: 26431302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous floaters: Etiology, diagnostics, and management.
    Milston R; Madigan MC; Sebag J
    Surv Ophthalmol; 2016; 61(2):211-27. PubMed ID: 26679984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel OCT Application and Optimized YAG Laser Enable Visualization and Treatment of Mid- to Posterior Vitreous Floaters.
    Singh IP
    Ophthalmic Surg Lasers Imaging Retina; 2018 Oct; 49(10):806-811. PubMed ID: 30395668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of vitrectomy for floaters--how safe is safe?
    Wilkinson CP
    Am J Ophthalmol; 2011 Jun; 151(6):919-920.e1. PubMed ID: 21616208
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of vitrectomy for floaters.
    Wa C; Sebag J
    Am J Ophthalmol; 2011 Dec; 152(6):1077; author reply 1077-8. PubMed ID: 22107935
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional and anatomical results of vitreopapillary traction after vitrectomy.
    Meyer CH; Schmidt JC; Mennel S; Kroll P
    Acta Ophthalmol Scand; 2007 Mar; 85(2):221-2. PubMed ID: 17305740
    [No Abstract]   [Full Text] [Related]  

  • 14. Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction.
    Schulz-Key S; Carlsson JO; Crafoord S
    Acta Ophthalmol; 2011 Mar; 89(2):159-65. PubMed ID: 19860781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment strategies for symptomatic vitreous opacities.
    Ryan EH
    Curr Opin Ophthalmol; 2021 May; 32(3):198-202. PubMed ID: 33710011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of posterior dislocation of IOL-CTR-CB complex.
    Saravan VR; Singh G; Sathyan P; Narendran V
    J Cataract Refract Surg; 2006 Dec; 32(12):1985-6. PubMed ID: 17137960
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitreous opacities and retinal vascular abnormalities in Gaucher disease.
    Shrier EM; Barr CC; Grabowski GA
    Arch Ophthalmol; 2004 Sep; 122(9):1395-8. PubMed ID: 15364726
    [No Abstract]   [Full Text] [Related]  

  • 18. The management of wound-related complications in pars plana vitrectomy.
    Kreiger AE
    Trans Am Ophthalmol Soc; 1994; 92():307-20; discussion 320-4. PubMed ID: 7886870
    [No Abstract]   [Full Text] [Related]  

  • 19. [Surgical tactics in removing various types of traumatic fibrous changes in the vitreous body].
    Kovalev AI
    Oftalmol Zh; 1988; (2):65-8. PubMed ID: 3399250
    [No Abstract]   [Full Text] [Related]  

  • 20. Complications of Treatment for Symptomatic Vitreous Floaters: A Review.
    Kakulavarapu S; Kiryakoza L; Sridhar J
    Int Ophthalmol Clin; 2022 Jul; 62(3):131-155. PubMed ID: 35752891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.